GSK sued Moderna for infringement of US patent rights for COVID and RSV vaccines

British drugmaker GlaxoSmithKline sued Moderna in a US federal court in Delaware, accusing the company of infringing GSK’s patent rights to GSK’s information RNA technology with its most popular COVID-19 vaccine Spikevax and RSV vaccine mResvia.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM